Edition:
India

Advaxis Inc (ADXS.OQ)

ADXS.OQ on NASDAQ Stock Exchange Global Select Market

3.01USD
22 Jan 2018
Change (% chg)

-- (--)
Prev Close
$3.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
214,881
52-wk High
$10.05
52-wk Low
$2.71

Chart for

About

Advaxis, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant... (more)

Overall

Beta: 2.03
Market Cap(Mil.): $187.67
Shares Outstanding(Mil.): 41.07
Dividend: --
Yield (%): --

Financials

BRIEF-Advaxis Says Expects Its Current Cash Position Will Be Sufficient To Fund Its Business Plan Into Fiscal 2019

* ADVAXIS REPORTS FISCAL YEAR 2017 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE

21 Dec 2017

BRIEF-Advaxis Q4 loss per share $1.74

* Advaxis reports business update and third quarter 2017 results

12 Sep 2017

Earnings vs. Estimates